Company Overview
Ardent Health, Inc. operates as a healthcare entity that owns and manages a network of hospitals and clinics delivering general and specialty medical services across the United States. This organization functions within the Healthcare sector, specifically classified under the Medical Care Facilities industry, positioning it as a provider of essential internal medicine, surgery, cardiology, oncology, and other specialized care. The company currently holds a market capitalization of $1.23B and generates annual revenue of $6.32B, while employing a workforce of 19,500 individuals. These valuation and revenue metrics indicate that Ardent Health is a mid-to-large-cap player with significant operational scale, yet the revenue figure relative to the market cap suggests a specific market valuation multiple that differs from high-growth technology peers. The substantial employee count of 19,500 reflects the labor-intensive nature of running a physical network of facilities, which is a primary driver of the company's cost structure and operational complexity. The breadth of services offered, ranging from neurology to urology, underscores the diversified revenue streams inherent in a large hospital network model.
Financial Health
The company reported total revenue of $6.32B over the trailing twelve months, resulting in a net income of $135.81M and an EBITDA of $481.29M. The significant gap between the $6.32B in revenue and the $135.81M in net income reveals a cost structure where operating expenses, including the compensation of 19,500 employees and facility maintenance, consume approximately 97.9% of gross revenue before interest and taxes are considered. Free cash flow stands at $155.97M, which provides the company with financial flexibility to service its obligations, maintain facilities, or pursue strategic acquisitions without relying solely on external financing. However, the balance sheet presents a mixed picture with cash holdings of $712.49M offsetting total debt of $2.32B, a configuration that results in a debt-to-equity ratio of 137.57. This high leverage ratio indicates that the company is currently utilizing a leveraged capital structure rather than a conservative one, relying heavily on borrowed capital to finance its asset base. Despite the high debt load, the current ratio of 1.97 suggests that the company maintains strong short-term liquidity, possessing nearly double the current assets required to cover its current liabilities. Return on Equity is measured at 14.4%, while Return on Assets sits at 4.0%, metrics that reveal management's effectiveness in generating returns relative to the shareholders' equity and the total asset base, respectively.
Valuation Assessment
The stock carries a trailing P/E ratio of 8.95 and a forward P/E of 7.34, implying that the market expects earnings to grow in the future as the forward multiple is lower than the trailing multiple. The price-to-book ratio is recorded at 0.95, indicating that the market is currently valuing the company at approximately 5% below its book value, which suggests the stock may be priced defensively relative to its tangible assets. Alternative valuation metrics show a price-to-sales ratio of 0.19 and an EV/EBITDA of 6.71, suggesting the company trades at a low multiple of both sales and enterprise earnings compared to typical industry averages. Regarding price volatility, the stock has a 52-week high of $15.48 and a 52-week low of $8.07; without a specific current price provided in the facts, the range defines the recent trading history, but the beta value is listed as N/A, meaning volatility relative to the broader market cannot be quantified from the available data. The disparity between the high and low prices of $15.48 and $8.07 highlights the recent price discovery phase of the security.
Growth & Income
Year-over-year revenue growth is -0.1%, while earnings growth is significantly lower at -60.6%, indicating that earnings are contracting much faster than revenue, which is unusual for a mature healthcare operator. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the company retains all its earnings rather than distributing them to shareholders. Instead of providing income through dividends, the firm reinvests its capital and free cash flow back into operations, debt reduction, or potential acquisitions to fuel organic growth or market share expansion. The overall growth and income profile for Ardent Health, Inc. is characterized by negative earnings momentum and a lack of dividend distribution, reflecting a capital allocation strategy focused on operational retention rather than shareholder yield.